In 2023, the FDA will likely approve Eli Lilly’s diabetes drug tirzepatide for weight loss — but there’s little indication insurers will widely cover the medication. An Eli Lilly drug if approved for weight loss could become the best-selling drug of all time, but concerns are mounting about…